Auckland City Hospital
Last Update: 2025-03-08 (UTC)
Between 900 and 1000
Excellent
Yolobh Universe 🪐🎓🏫👩🏫👽👾🛸✅🇮🇳🥰🔐🔜
NAICS: 541
NAICS Definition:
Employees: 764
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0
Comparison Overview
Auckland City Hospital
VS
Roche
Roche
Last Update: 2025-05-27 (UTC)
Strong
Between 800 and 900
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI). For more information, please visit https://careers.roche.com Read our community guidelines here: https://www.roche.com/some-guidelines.htm #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation
NAICS: 541714
NAICS Definition: Research and Development in Biotechnology (except Nanobiotechnology)
Employees: 99,293
Subsidiaries: 51
12-month incidents
0
Known data breaches
0
Attack type number
0
Compliance Badges Comparison
Security & Compliance Standards Overview
Auckland City Hospital
ISO 27001
Not verified
SOC 2
Not verified
GDPR
No public badge
PCI DSS
No public badge
Roche
ISO 27001
Not verified
SOC 2
Not verified
GDPR
No public badge
PCI DSS
No public badge
Compliance Summary
Auckland City Hospital
100%
Compliance Rate
0/4 Standards Verified
Roche
0%
Compliance Rate
0/4 Standards Verified
Benchmark & Cyber Underwriting Signals
Incidents vs Biotechnology Research Industry Average (This Year)
No incidents recorded for Auckland City Hospital in 2025.
Incidents vs Biotechnology Research Industry Average (This Year)
No incidents recorded for Roche in 2025.
Incident History — Auckland City Hospital (X = Date, Y = Severity)
Auckland City Hospital cyber incidents detection timeline including parent company and subsidiaries
Incident History — Roche (X = Date, Y = Severity)
Roche cyber incidents detection timeline including parent company and subsidiaries
Notable Incidents
Last 3 Security & Risk Events by Company
Auckland City Hospital
Incidents
No Incident
Roche
Incidents
No Incident
FAQ
Auckland City Hospital company company demonstrates a stronger AI risk posture compared to Roche company company, reflecting its advanced AI governance and monitoring frameworks.
Historically, Roche company has disclosed a higher number of cyber incidents compared to Auckland City Hospital company.
In the current year, Roche company and Auckland City Hospital company have not reported any cyber incidents.
Neither Roche company nor Auckland City Hospital company has reported experiencing a ransomware attack publicly.
Neither Roche company nor Auckland City Hospital company has reported experiencing a data breach publicly.
Neither Roche company nor Auckland City Hospital company has reported experiencing targeted cyberattacks publicly.
Neither Auckland City Hospital company nor Roche company has reported experiencing or disclosing vulnerabilities publicly.
Roche company has more subsidiaries worldwide compared to Auckland City Hospital company.
Roche company employs more people globally than Auckland City Hospital company, reflecting its scale as a Biotechnology Research.
Latest Global CVEs (Not Company-Specific)
Description
A weakness has been identified in bftpd up to 6.2. Impacted is the function expand_groups of the file options.c of the component Configuration File Handler. Executing manipulation can lead to heap-based buffer overflow. It is possible to launch the attack on the local host. Attacks of this nature are highly complex. The exploitability is considered difficult. The exploit has been made available to the public and could be exploited. The vendor was contacted early about this disclosure but did not respond in any way.
Risk Information
cvss2
Base: 3.5
Severity: HIGH
AV:L/AC:H/Au:S/C:P/I:P/A:P
cvss3
Base: 4.5
Severity: HIGH
CVSS:3.1/AV:L/AC:H/PR:L/UI:N/S:U/C:L/I:L/A:L
cvss4
Base: 2.0
Severity: HIGH
CVSS:4.0/AV:L/AC:H/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description
A security flaw has been discovered in LogicalDOC Community Edition up to 9.2.1. This issue affects some unknown processing of the file /frontend.jsp of the component Add Contact Page. Performing manipulation of the argument First Name/Last Name/Company/Address/Phone/Mobile results in cross site scripting. Remote exploitation of the attack is possible. The exploit has been released to the public and may be exploited. The vendor was contacted early about this disclosure but did not respond in any way.
Risk Information
cvss2
Base: 4.0
Severity: LOW
AV:N/AC:L/Au:S/C:N/I:P/A:N
cvss3
Base: 3.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:N/I:L/A:N
cvss4
Base: 5.1
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description
A vulnerability was identified in toeverything AFFiNE up to 0.24.1. This vulnerability affects unknown code of the component Avatar Upload Image Endpoint. Such manipulation leads to cross site scripting. The attack may be launched remotely. The exploit is publicly available and might be used. The vendor was contacted early about this disclosure but did not respond in any way.
Risk Information
cvss2
Base: 4.0
Severity: LOW
AV:N/AC:L/Au:S/C:N/I:P/A:N
cvss3
Base: 3.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:N/I:L/A:N
cvss4
Base: 5.1
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description
A vulnerability was determined in givanz Vvveb up to 1.0.7.3. This affects the function Import of the file admin/controller/tools/import.php of the component Raw SQL Handler. This manipulation causes sql injection. The attack may be initiated remotely. The exploit has been publicly disclosed and may be utilized. Patch name: 52204b4a106b2fb02d16eee06a88a1f2697f9b35. It is recommended to apply a patch to fix this issue.
Risk Information
cvss2
Base: 5.8
Severity: LOW
AV:N/AC:L/Au:M/C:P/I:P/A:P
cvss3
Base: 4.7
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:L/I:L/A:L
cvss4
Base: 5.1
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description
A vulnerability has been found in 70mai X200 up to 20251010. Affected by this vulnerability is an unknown functionality of the component HTTP Web Server. The manipulation leads to use of default credentials. The attack can be initiated remotely. The exploit has been disclosed to the public and may be used. The vendor was contacted early about this disclosure but did not respond in any way.
Risk Information
cvss2
Base: 7.5
Severity: LOW
AV:N/AC:L/Au:N/C:P/I:P/A:P
cvss3
Base: 7.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
